Synthesis and characterization of novel chitosan nanocomposite hydrogels for drug delivery and bone tissue engineering

• Autorzy: Pazdan K. , Pielichowska K. , Chłopek J.
• Języki publikacji: EN

Abstrakty

EN

Biodegradable materials for drug delivery and bone tissue engineering are currently intensively developing and improving, but there are still a lot of problems to solve related with bioactivity, biocompatibility, release profile etc. Osteosarcoma is an aggressive malignant neoplasm arising from primitive transformed cells of mesenchymal origin that exhibit osteoblastic differentiation and produce malignant osteoid. It is the most common histological form of primary bone cancer [1,2]. Treatment is most destinations and made up for: intensive multidrug short induction chemotherapy, amputation or tumor resection within the limits of normal tissue and in the last phase again chemotherapy. This kind of neoplasm is most recently detected in young male till 25 age, therefore improving methods of treatment is so important. Chitosan is a natural-based polymer obtained by alkaline deacetylation of chitin received from powdered shrimp shells was purchased from Acros Organics. Its main advantages are non-toxic, non-immunogenic, non-carcinogenic degradation products, biocompatible, bioactive and biodegradable. These properties cause chitosan a very good candidate for novel hydrogel drug delivery systems. Chitosan easily forms hydrogel particles and entraps biomolecules through a number of mechanisms, including chemical crosslinking, ionic crosslinking, and ionic complexation [3,4]. A possible alternative of chitosan by the chemical modification also has been useful for the association of bioactive molecules to polymer and controlling the drug release profile. There are few methods of modification, or example.: copolimerization, grafting, chemical and ionic crosslinking, polyelectrolyte complexes, etc [5]. Previous studies demonstrated that chitosan could promote the proliferation and osteogenesis but only with moderate swelling ratio of composite, too high ability of entrapment water solutions are not recommended. There are a lot of advantages in chitosan properties that can be used in research work to obtain the material of the best expected properties. Laponite® (LA) is a plate-like synthetic clay hectoritetype belongs to a family of phyllosolicates type 2:1 [6]. Its structure represent empirical formula: Na0.7+[Si8Mg5.5Li0.3 O20(OH)4]0.7-. The plates size is about 25 nm x 0,92 nm. LA has a large surface area, anionic surface charges and exchangeable Na+ cations in hydrated interlayers. Presence of sodium cations causes better adsorption properties for cationic drug molecules. Moreover, the exfoliated LA particles may act as multifunctional crosslinkers in forming the nanocomposite hydrogels, and the polymer chains were anchored to the particles and entangled to form a network [7]. Used synthetic clay has got the same type structure and but better sorption properties to montmorillonite but it has got serious advantage - as a synthetic compound shows low heavy metal content. The initial results indicate that the incorporation of clay improved the swelling behavior in contrast to the pure chitosan beads. There also had been revealed significant disproportion of viscosity received hydrogels according to different type of LA or different concentration. Increasing content causes telling rise of viscosity, especially reported in higher content of used crosslinker. The aim of research is to develop a bioactive system biopolymer/layered silicate intelligent nanocomposite based on chitosan and synthetic clay by a cross-linking reaction using sodium tripolyphosphate as the gel factor. The resultant composite were characterized by Fourier transform infrared spectroscopy, scanning electronic microscope and X-ray diffraction analysis. The bioactivity in physiological pH solution (SBF pH=7.40) [8], drug encapsulation efficiency and controlled release behaviour were also investigated by using the model drug to reveal the effects of introduced LA.

Słowa kluczowe

EN

nanocomposites; tissue engineering; hydrogels

• Wydawca: Polish Society for Biomaterials in Cracow
• Czasopismo: Engineering of Biomaterials
• Rocznik: 2013
• Tom: Vol. 16, no. 122-123 spec. iss.
• Strony: 1--2
• Opis fizyczny: Bibliogr. 8 poz., rys.

Twórcy

autor

Pazdan K.

• AGH University of Science and Technology, Faculty of Materials Science and Ceramics Department of Biomaterials, 30 Mickiewicza Av. 30-059 Kraków, Poland

autor

Pielichowska K.

• AGH University of Science and Technology, Faculty of Materials Science and Ceramics Department of Biomaterials, 30 Mickiewicza Av. 30-059 Kraków, Poland

autor

Chłopek J.

• AGH University of Science and Technology, Faculty of Materials Science and Ceramics Department of Biomaterials, 30 Mickiewicza Av. 30-059 Kraków, Poland

Bibliografia

• [1] Zheng M., Han B., Yang Y., Liu W.: Synthesis, characterization and biological safety of O-carboxymethyl chitosan used to treat Sarcoma 180 tumor. Carbohydrate Polymers 86 (2011) 231-238
• [2] Lewandowska-Szumieł M., Komender, J., Chłopek, J.: Interaction between carbon composites and bone after intrabone implantation. Journal of Biomedical Materials Research 48/3 (1999) 289-296
• [3] Pielichowska K., Błażewicz S., Bioactive polymer/hydroxyapatite (nano)composites for bone tissue regeneration. Advances in Polymer Science 2010, 232, 97–207.
• [4] Ta H.T., Dass C.R., Dunstan D.E.: Injectable chitosan hydrogels for localised cancer therapy. Journal of Controlled Release 126 (2008) 205-216
• [5] TGiri T.K., Thakur A., Alexander A., Ajazuddin, Badwaik H., Tripathi D.K.: Modified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications. Acta Pharmaceutica Sinica B 2/5 (2012) 439-449
• [6] http://www.laponite.com (10.07.2013)
• [7] Yang H., Hua S., Wenbo Wang W., Wang A.: Composite Hydrogel Beads Based on Chitosan and Laponite: Preparation, Swelling, and Drug Release Behaviour. Iranian Polymer Journal 20/6 (2011) 479-490
• [8] Kokubo T., Takadama H.: How useful is SBF in predicting in vivo bone bioactivity. Biomaterials 27 (2006) 2907–2915 Manufacturing Engineering 17 (2006) 423-426.

Uwagi

EN

Research funded under statutory researches 11.11.160.256.